4.0 Article

Proteomic Analysis by Two-Dimensional Electrophoresis to Identify the Normal Human Chondrocyte Proteome Stimulated by Tumor Necrosis Factor α and Interleukin-1β

Journal

ARTHRITIS AND RHEUMATISM
Volume 62, Issue 3, Pages 802-814

Publisher

WILEY
DOI: 10.1002/art.27265

Keywords

-

Categories

Funding

  1. Fondo Investigacion Sanitaria of Spain [CIBER-CB06/01/0040, PI-08/2028]
  2. Ministerio de Educacion y Ciencia [SAF 2005-06211]
  3. Secretaria I+D+I Xunta de Galicia [PGIDIT06PXIC916175PN, PXIB916357PR, PGIDIT06PXIB916358PR]
  4. Fondo Investigacion Sanitaria [FI05/00261]
  5. Programa Parga Pondal, Secretaria Xeral I+D+I, Xunta de Galicia
  6. Contrato Investigadores SNS

Ask authors/readers for more resources

Objective. To determine the intracellular proteome of normal human chondrocytes stimulated with interleukin-1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF alpha) and to ascertain differences in the protein expression patterns of these 2 cytokines. Methods. Normal human knee cartilage chondrocytes were incubated for 48 hours without stimulation or stimulated with IL-1 beta (5 ng/ml) or with TNF alpha (10 ng/ml). For each culture condition, protein extracts from 4 normal subjects were pooled and resolved using 2-dimensional electrophoresis. Protein spots were visualized with Sypro stain, and qualitative and quantitative analyses were performed using PDQuest software. Protein spots were then identified by mass spectrometry, using matrix-assisted laser desorption ionization-time-of-flight/time-of-flight technology. Results. We identified 37 spots by mass spectrometry (MS) or by MS/MS, corresponding to 35 different proteins. In IL-1 beta-stimulated chondrocytes, IL-1 beta was found to modulate 22 proteins, as compared with unstimulated chondrocytes. All of these proteins except connective tissue growth factor (CCND2) were up-regulated. Proteins involved in cellular metabolism and energy (23%) that were up-regulated or induced by IL-1 beta included nicotinamide phosphoribosyltransferase, long-chain fatty acid-coenzyme A ligase 4, delta-aminolevulinic acid dehydratase, triosephosphate isomerase, and an isoform of glyceraldehyde-3-phosphate dehydrogenase. In TNF alpha-stimulated chondrocytes, TNF alpha was found to modulate 20 proteins, as compared with unstimulated chondrocytes. All of these except chitinase 3-like 1 (cartilage glycoprotein 39), proteasome activator complex subunit 2, and G3PDH, were up-regulated. Eighteen proteins were differently modulated by IL-1 beta and TNF alpha. Of these, 45% were related to metabolism. Conclusion. IL-1 beta and TNF alpha induce different profiles of intracellular protein expression in healthy human chondrocytes. Most of the proteins that are differently regulated are proteins that are implicated in the generation of cellular energy and in glycolysis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

Francis Berenbaum, Francisco J. Blanco, Ali Guermazi, Kenji Miki, Takaharu Yamabe, Lars Viktrup, Rod Junor, William Carey, Mark T. Brown, Christine R. West, Kenneth M. Verburg

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Biochemical Research Methods

Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis

Nuria Colome, Joaquin Abian, Kerman Aloria, Jesus M. Arizmendi, Silvia Barcelo-Batllori, Sophie Braga-Lagache, Odile Burlet-Schiltz, Montse Carrascal, J. Ignacio Casal, Eduard Chicano-Galvez, Cristina Chiva, Luis Felipe Clemente, Felix Elortza, Josep M. Estanyol, Joaquin Fernandez-Irigoyen, Patricia Fernandez-Puente, Maria Jose Fidalgo, Carine Froment, Manuel Fuentes, Carlos Fuentes-Almagro, Marina Gay, Alexandre Hainard, Manfred Heller, Maria Luisa Hernandez, Nieves Ibarrola, Ibon Iloro, Thomas Kieselbach, Antonio Lario, Marie Locard-Paulet, Anabel Marina-Ramirez, Luna Martin, Esperanza Morato-Lopez, Javier Munoz, Rosana Navajas, M. Antonia Odena, Leticia Odriozola, Eliandre de Oliveira, Alberto Paradela, Carla Pasquarello, Vivian de los Rios, Cristina Ruiz-Romero, Eduard Sabido, Manuel Sanchez del Pino, Jaime Sancho, Enrique Santamaria, Christine Schaeffer-Reiss, Justine Schneider, Carolina de la Torre, M. Luz Valero, Marta Vilaseca, Shuai Wu, Linfeng Wu, Pilar Ximenez de Embun, Francesc Canals, Fernando J. Corrales

Summary: Global analysis of protein phosphorylation using mass spectrometry has become a powerful tool in biological and biomedical research, but it presents challenges such as low stoichiometry and the need for residue-specific information. The Proteomics Multicentric Experiment 11 (PME11) was launched to investigate the performance of phosphoprotein analysis protocols, with a reference sample distributed to 31 laboratories for evaluation. The results indicate the suitability of the PME11 reference sample for benchmarking and optimizing phosphoproteomics strategies while evaluating intra and inter laboratory performance.

JOURNAL OF PROTEOMICS (2022)

Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction and Oxidative Stress in Rheumatoid Arthritis

Maria Jose Lopez-Armada, Jennifer Adriana Fernandez-Rodriguez, Francisco Javier Blanco

Summary: Controlling excessive mitochondrial oxidative stress can provide new targets for the treatment of chronic inflammation or diseases such as rheumatoid arthritis (RA). Mitochondrial alterations play a role in autoimmune diseases through the interaction between metabolism and innate immunity. Mitochondrial dysfunction can activate inflammatory pathways and impact cell death and epigenetic regulation. Additionally, there may be a relationship between dietary components and the onset and progression of RA.

ANTIOXIDANTS (2022)

Article Orthopedics

Test-retest precision and longitudinal cartilage thickness loss in the IMI-APPROACH cohort

W. Wirth, S. Maschek, A. C. A. Marijnissen, A. Lalande, F. J. Blanco, F. Berenbaum, L. A. van de Stadt, M. Kloppenburg, I. K. Haugen, C. H. Ladel, J. Bacardit, A. Wisser, F. Eckstein, F. W. Roemer, F. P. J. G. Lafeber, H. H. Weinans, M. Jansen

Summary: The study aims to investigate the test-retest precision of cartilage thickness and report longitudinal changes in the IMI-APPROACH cohort. The machine-learning-estimated structural progression score (s-score) was not predictive of cartilage thickness loss.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Medicine, General & Internal

Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies

Cristina Ruiz-Romero, Patricia Fernandez-Puente, Lucia Gonzalez, Anna Illiano, Lucia Lourido, Rocio Paz, Patricia Quaranta, Eva Perez-Pampin, Antonio Gonzalez, Francisco J. Blanco, Valentina Calamia

Summary: This study utilizes a proteomic biomarker pipeline to analyze the molecular changes associated with the RF and ACPA status of rheumatoid arthritis patients. The results identify specific proteins that show altered abundance in relation to RF and ACPA status, and two putative biomarkers, A1AG1 and HPT, are validated as increased in the double seropositive group. These findings provide valuable information for the stratification and personalized medicine of rheumatoid arthritis patients.

FRONTIERS IN MEDICINE (2022)

Article Orthopedics

Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohort

Frank W. Roemer, Mylene Jansen, Anne C. A. Marijnissen, Ali Guermazi, Rafael Heiss, Susanne Maschek, Agnes Lalande, Francisco J. Blanco, Francis Berenbaum, Lotte A. van de Stadt, Margreet Kloppenburg, Ida K. Haugen, Christoph H. Ladel, Jaume Bacardit, Anna Wisser, Felix Eckstein, Floris P. J. G. Lafeber, Harrie H. Weinans, Wolfgang Wirth

Summary: The IMI-APPROACH cohort used MRI evaluation to study the characteristics of knee osteoarthritis, and found that the baseline prevalence and change of features were more common in knees with radiographic OA.

BMC MUSCULOSKELETAL DISORDERS (2022)

Article Biochemistry & Molecular Biology

In Vitro Study of the Therapeutic Potential of Brown Crude Fucoidans in Osteoarthritis Treatment

Carlos Vaamonde-Garcia, Emma Capelo-Mera, Noelia Florez-Fernandez, Maria Dolores Torres, Beatriz Rivas-Murias, Rosa Mejide-Failde, Francisco J. Blanco, Herminia Dominguez

Summary: This study analyzed the therapeutic potential of crude fucoidans in chondrocytes and found that they have partial effectiveness in alleviating inflammation and oxidative stress associated with osteoarthritis, but do not attenuate chondrocyte senescence.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemical Research Methods

Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project

Manuel Fuentes, Cristina Ruiz-Romero, Sara Misiego, Pablo Juanes-Velasco, Alicia Landeira-Vinuela, Adrian Torres-Roda, Hector Lorenzo-Gil, Maria Gonzalez-Gonzalez, Angela P. Hernandez, Lucia Lourido, Ronald Sjoberg, Elisa Pin, Javier de Las Rivas, Jose Manuel Sanchez-Santos, Peter Nilsson, Francisco J. Blanco

Summary: Rheumatic diseases are common and complex conditions with low sensitivity to clinical diagnosis. This study developed an early diagnosis method for personalized treatment based on the identification of relevant proteins associated with the specific pathologies. By utilizing functional proteomics screening, a panel of 30 serum proteins has been identified as potential biomarkers for rheumatic diseases such as osteoarthritis, rheumatoid arthritis, and psoriatic arthritis.

JOURNAL OF PROTEOME RESEARCH (2023)

Article Rheumatology

Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK an Open-Label Phase IV Trial

Filip Van den Bosch, James Cheng-Chung Wei, Peter Nash, Francisco J. Blanco, Daniela Graham, Chuanbo Zang, Edmund Arthur, Cecilia Borlenghi, Vassilis Tsekouras, Bonnie Vlahos, Atul Deodhar

Summary: This study investigated the withdrawal and retreatment of etanercept in patients with nr-axSpA achieving inactive disease. The results showed that approximately 25% of patients maintained inactive disease for 40 weeks after discontinuing etanercept. Baseline absence of MRI sacroiliitis and high hs-CRP predicted response maintenance after etanercept withdrawal.

JOURNAL OF RHEUMATOLOGY (2023)

Review Chemistry, Medicinal

Epigenetics as a Therapeutic Target in Osteoarthritis

Carmen Nunez-Carro, Margarita Blanco-Blanco, Karla Mariuxi Villagran-Andrade, Francisco J. Blanco, Maria C. de Andres

Summary: In this study, we reviewed the current understanding of epigenetic mechanisms in relation to the pathogenesis of OA, particularly in articular cartilage. Evidence suggests that dysregulation of crucial cartilage molecules is a result of aberrant epigenetic regulatory mechanisms, which contribute to the development and progression of OA. This provides an opportunity to explore new therapeutic targets and novel biomarkers for the disease.

PHARMACEUTICALS (2023)

Article Rheumatology

A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

Alejandro Duran-Sotuela, Mercedes Fernandez-Moreno, Victoria Suarez-Ulloa, Jorge Vazquez-Garcia, Sara Relano, Tamara Hermida-Gomez, Vanesa Balboa-Barreiro, Lucia Lourido-Salas, Valentina Calamia, Patricia Fernandez-Puente, Cristina Ruiz-Romero, Juan Fernandez-Tajes, Carlos Vaamonde-Garcia, Maria C. de Andres, Natividad Oreiro, Francisco J. Blanco, Ignacio Rego-Perez

Summary: This study aimed to investigate the genetic variants in mitochondrial DNA (mtDNA) associated with the risk of rapid progression of knee osteoarthritis (OA) and evaluate their functional significance using a cellular model. The results showed that the mtDNA variant m.16519C was associated with an increased risk of rapid progression of knee OA. The cellular model study further revealed mitochondrial dysfunction and impaired autophagy in cells harboring this variant, which were related to inflammation in OA.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Orthopedics

Defective chaperone-mediated autophagy is a hallmark of joint disease in patients with knee osteoarthritis

I. Lorenzo-Gomez, U. Nogueira-Recalde, C. Garcia-Dominguez, N. Oreiro-Villar, M. Lotz, J. A. Pinto-Tasende, F. J. Blanco, B. Carames

Summary: Defects in autophagy contribute to joint aging and Osteoarthritis (OA). Identifying specific autophagy types could be useful for developing novel treatments for OA.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Cell & Tissue Engineering

Generation of human immortalized chondrocytes from osteoarthritic and healthy cartilage A NEW TOOL FOR CARTILAGE PATHOPHYSIOLOGY STUDIES

M. Pineiro-Ramil, C. Sanjurjo-Rodriguez, S. Rodriguez-Fernandez, T. Hermida-Gomez, F. J. Blanco-Garcia, I. Fuentes-Boquete, C. Vaamonde-Garcia, S. Diaz-Prado

Summary: The aim of this study was to develop immortalized chondrocyte cell lines from articular cartilage of patients with and without osteoarthritis (OA). By transducing primary articular chondrocytes with telomerase reverse transcriptase (hTERT) and SV40 large T antigen (SV40LT), the researchers successfully immortalized the chondrocytes. Although these cell lines were unable to synthesize cartilage-like tissue under the experimental conditions, they retained the ability to respond to IL-113 cytokine, making them advantageous for OA investigation.

BONE & JOINT RESEARCH (2023)

Article Cell Biology

mtDNA variability determines spontaneous joint aging damage in a conplastic mouse model

Morena Scotece, Carlos Vaamonde-Garcia, Ana Victoria Lechuga-Vieco, Alberto Centeno Cortes, Maria Concepcion Jimenez Gomez, Purificacion Filgueira-Fernandez, Ignacio Rego-Perez, Jose Antonio Enriquez, Francisco J. Blanco

Summary: This study reveals that mtDNA variations have an impact on joint damage during the aging process. By using a conplastic mouse model, it is shown that genetic manipulation of mtDNA can ameliorate joint aging damage, indicating that mtDNA variability is a prognostic factor for aging-related osteoarthritis (OA).

AGING-US (2022)

No Data Available